期刊文献+

前列腺癌根治术后复发的诊断和治疗 被引量:4

Diagnosis and treatment for local recurrence and metastasis of patients after radical prostatectomy
下载PDF
导出
摘要 临床局限型前列腺癌患者在接受根治术后有一部分会发生生化复发,生化复发是肿瘤继续进展并发生临床复发或转移的前兆。术后随访中检出生化复发患者,进行恰当的评估,可以筛选出高危患者接受进一步治疗。挽救性放疗和内分泌治疗对前列腺癌根治术后复发或转移的患者有一定的疗效。本文综述了前列腺癌根治术后复发和转移的诊断方法和治疗选择的进展。 The incidence of biochemical recurrence after radical prostatectomy varies significantly and depends on numerous well-known prognostic factors. It likely occurs in at least 30% - 40% of patients who were diagnosed as localized disease and received radical prostatectomy. Because the clinical significance of biochemical recurrence is often unclear and other predictive factors relative to the recurrence are uncertain, it is difficult to select the best treatment for the patients who might relapse in the future. This review examines some of the issues associated with biological recurrence and attempts to shed some light on this common but controversial clinical scenario. Some treatment strategies were discussed in this article including salvage radiotherapy after radical prostatectomy, watchful waiting, and hormonal therapy.
出处 《中国癌症杂志》 CAS CSCD 2007年第3期193-198,共6页 China Oncology
关键词 前列腺肿瘤 复发 转移 诊断 治疗 prostate neoplasm recurrence metastasis diagnosis therapy
  • 相关文献

参考文献32

  • 1Grossfeld GD,Stier DM,Flanders SC,et al.Use of second treatment following definitive local therapy for prostate cancer:data from the caPSURE database[J].J Urol 1998,160:1398-1404.
  • 2Yao LGL,Potosky AL,Albertsen PC,et al.Follow-up prostate cancer treatments after radical prostatectomy:a population-based study[J].J Natl Cancer Inst 1996,88:166-173.
  • 3Bott SRJ.Management of recurrent disease after radical prostatectomy[J].Prostate Cancer Prostatic Dis 2004,7:211-216.
  • 4Lange PH,Ercole CJ,Lightner DJ,et al.The value of serum prostate specific antigen determinations before and after radical prostatectomy[J].J Urol 1989,141:873-879.
  • 5Pound CR,Partin AW,Eisenberger MA,et al.Natural history of progression after PSA elevation following radical prostatectomy[J].JAMA 1999,281:1591-1597.
  • 6Polascik TJ,Oesterling JE,Partin AW.Prostate specific antigen:a decade of discovery-what we have learned and where we are going[J] J Urol 1999,162:293-306.
  • 7Moul JW.Prostate specific antigen only progression of prostate cancer[J].J Urol 2000,163:1632-1642.
  • 8Amling CL,Bergstralh EJ,Blute ML,et al.Defining prostate specific antigen progression after radical prostatectomy:what is the most appropriate cut point[J]? J Urol 2001,65:1146-1151.
  • 9Chay C,Smith DC.Adjuvant and neoadjuvant therapy in prostate cancer[J].Semin Oncol 2001,28(1):3-12.
  • 10Babaian RJ,Troncoso P,Bhadkamkar VA,et al.Analysis of clinicopathologic factors predicting outcome after radical prostatectomy[J].Cancer 2001,91:1414-1422.

同被引文献53

  • 1徐勇刚,李高峰,吴钦宏,高鸿,李雪南,刘明远.前列腺癌放疗方法的剂量学研究[J].中华放射肿瘤学杂志,2007,16(2):125-128. 被引量:4
  • 2Aus G.Eur Urol 2007;51(5):1155-1157;discussion 1157-1158.
  • 3Pijoan JM.Arch Esp Urol 2006;59(10):1053-1062.
  • 4Maffezzini M,Bossi A,Collette L,et al.E,ur Uro12007;51(3):605-613;discussion 613.
  • 5D'Amico A.RIU Int 2007;99Suppl 1:13-16;discussion 17-18.
  • 6Pound CR,Partin AW,Eisenberger MA,et al.JAMA 1999;281(17):1591-1597.
  • 7Milecki P,Kwias Z,Martenka D J,et al.Neoplasma 2007;54(1):7-15.
  • 8Nguyen PL,D'Amico AV,Lee AK,et al.Cancer 2007;110(7):1417-1428.
  • 9Freedland SJ,Moui JW,et al.J Urol 2007;177(6):1985-1991.
  • 10Moul JW.Curr Pharm Des 2006;12:785-798.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部